Global Biosimilar Monoclonal Antibodies Market Size study, by Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), by Indication (Oncology, Autoimmune Diseases, Others), by End User (Hospitals, Cancer Treatment Centers, Others), and Regional Forecasts 2022-2032
2025/05/25
4,950 USD